Thyroid treatment may improve gut health in people with hypothyroidism

People with an underactive thyroid may increase the risk of developing small intestinal bacteria (SIBO), a risk that may be reduced with thyroid hormone treatment, according to a study, according to a study, Saturday is being presented on Saturday according to a study. Endo 2025Annual meeting of Endocrine Society at San Francisco, California.

“Now we know that people are together HypothyroidismEspecially with autoimmune thyroiditis, SIBO is more likely to develop, but this risk seems to be less among those taking thyroid drugs, “Ruchi Mathur, MD, Director of Diabetes Outpatting Heal Treatment and Education Center and Director of Operations of Center for Center for Center for Center and Medical Sciences and Technology in Losa Angelles, California.

Mathur said that his research also shows that there may be a microorganological mechanism running this association, which can lead to more personal treatment.

Researchers examined the relationship between SIBO and Hypothyroidism in people over the age of 18, who first passed through the upper endoscopy without a colon and reported to live with control with hypothyroidism. The subjects were recruited through his leading remagin study.

He analyzed small bowel fluid samples from 49 people with hypothyroidism and demonstrated DNA sequencing to identify microbial species without a 323 position. The results showed that people with hypothyroidism had a significant circulation of Sibo than control (33% vs. 15%).

Mathur and colleagues further evaluated four groups: Sibo-positive with hypothyroidism, SIBO-negative with hypothyroidism, without SIBO-positive thyroid diseaseAnd Sibo-negative without thyroid disease.

The analysis showed various patterns of bacteria in the intestine depending on a person’s thyroid position and co-event of SIBO.

Separately, he analyzed a massive analysis of medical records from the Trinetx database, which looked at the 10-year risks of developing SIBO in people with hypothyroidism or autoimmune thyroiditis compared to matching controls. Risks were also reduced in people taking levothyroxine.

“Results showed that the risk of developing SIBO in subjects with hypothyroidism is 2.2 times higher than the risk in a matching control cohort and with autoimmune thyroiditis compared to a matching control group, it was 2.4 times more. MDIS, MDIS said.

“These findings open the door for new screening and prevention strategies. For example, the doctor can start monitoring thyroid health more closely in patients with SIBO, and on the contrary. Said. “As the research continues, this may lead to more personal care and intervention for pre -risk individuals.”